159 related articles for article (PubMed ID: 38155632)
21. Gliosarcoma with chondroblastic osteosarcomatous differentation: report of two case with clinicopathologic and immunohistochemical features.
Barut F; Kandemir NO; Ozdamar SO; Gul S; Bektas S; Gun BD; Bahadir B
Turk Neurosurg; 2009 Oct; 19(4):417-22. PubMed ID: 19847765
[TBL] [Abstract][Full Text] [Related]
22. Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Dardis C; Donner D; Sanai N; Xiu J; Mittal S; Michelhaugh SK; Pandey M; Kesari S; Heimberger AB; Gatalica Z; Korn MW; Sumrall AL; Phuphanich S
BMC Neurol; 2021 Jun; 21(1):231. PubMed ID: 34162346
[TBL] [Abstract][Full Text] [Related]
23. Temporal gliosarcoma with extraneural metastasis: case report.
Maeda D; Miyazawa T; Toyooka T; Shima K
Neurol Med Chir (Tokyo); 2010; 50(4):343-5. PubMed ID: 20448433
[TBL] [Abstract][Full Text] [Related]
24. Primary Gliosarcoma with Extracranial Metastasis.
Choi MG; Lee JH; Lee MS; Suh SJ; Lee YS; Kang DG
Brain Tumor Res Treat; 2020 Apr; 8(1):53-56. PubMed ID: 32390354
[TBL] [Abstract][Full Text] [Related]
25. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Boerman RH; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap AK; Scheithauer BW; Jenkins RB
J Neuropathol Exp Neurol; 1996 Sep; 55(9):973-81. PubMed ID: 8800093
[TBL] [Abstract][Full Text] [Related]
26. Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report.
Cheong JH; Kim CH; Kim JM; Oh YH
Clin Neurol Neurosurg; 2010 Oct; 112(8):701-6. PubMed ID: 20466481
[TBL] [Abstract][Full Text] [Related]
27. Gliosarcoma with osteosarcomatous differentiation: review of radiological and pathological features.
Alatakis S; Stuckey S; Siu K; McLean C
J Clin Neurosci; 2004 Aug; 11(6):650-6. PubMed ID: 15261243
[TBL] [Abstract][Full Text] [Related]
28. Gliosarcoma with unusual glial components: Two case reports.
Otsu Y; Matsumoto Y; Higaki K; Furuta T; Moritsubo M; Yoshitake H; Nagata Y; Hashikawa T; Sakai H; Nakagawa S; Takahashi K; Sugita Y
Neuropathology; 2022 Aug; 42(4):282-288. PubMed ID: 35644835
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
30. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.
Cho SY; Park C; Na D; Han JY; Lee J; Park OK; Zhang C; Sung CO; Moon HE; Kim Y; Kim JH; Kim JJ; Khang SK; Nam DH; Choi JW; Suh YL; Kim DG; Park SH; Youn H; Yun K; Kim JI; Lee C; Paek SH; Park H
Exp Mol Med; 2017 Apr; 49(4):e317. PubMed ID: 28408749
[TBL] [Abstract][Full Text] [Related]
32. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
33. A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component.
Ishikawa R; Kadota K; Hayashi T; Kimura N; Inoue K; Ibuki E; Kagawa S; Kushida Y; Okada M; Miyake K; Tamiya T; Nobusawa S; Hirato J; Haba R
Pathol Int; 2020 Mar; 70(3):166-170. PubMed ID: 31903645
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
35. Gliosarcoma case report and review of the literature.
Awadalla AS; Al Essa AM; Al Ahmadi HH; Al Ojan A; Muazen Y; Alsayyah A; Alsaif H; Alsafwani NS
Pan Afr Med J; 2020; 35():26. PubMed ID: 32341747
[TBL] [Abstract][Full Text] [Related]
36. Brachium Pontis Gliosarcoma With Well-Differentiated Cartilaginous Tissue: A Case Report.
Wang L; Xie Y; Liu Y; Tan J; Chen Z; Xiao Y; Xia Y; Peng Z
Medicine (Baltimore); 2015 Oct; 94(42):e1735. PubMed ID: 26496287
[TBL] [Abstract][Full Text] [Related]
37. [Secondary gliosarcoma: case report].
Tahri R; Boulahroud O; Setti K; Oukabli M; El Ochi MR; Akhaddar A; Boucetta M; Albouzidi A
Ann Pathol; 2012 Apr; 32(2):147-50. PubMed ID: 22520611
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry of gliosarcoma with liposarcomatous differentiation.
Fukuda T; Yasumichi K; Suzuki T
Pathol Int; 2008 Jun; 58(6):396-401. PubMed ID: 18477220
[TBL] [Abstract][Full Text] [Related]
39. Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma.
Jimenez C; Powers M; Parsa AT; Glastonbury C; Hagenkord JM; Tihan T
J Neurooncol; 2011 Nov; 105(2):317-23. PubMed ID: 21533839
[TBL] [Abstract][Full Text] [Related]
40. Genetic and pathologic evolution of early secondary gliosarcoma.
Codispoti KE; Mosier S; Ramsey R; Lin MT; Rodriguez FJ
Brain Tumor Pathol; 2014 Jan; 31(1):40-6. PubMed ID: 23324827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
